Literature DB >> 15236090

Three approaches to pathophysiology of shock.

M Miyazaki1, S Yokono, C Okuda, T Mizobe.   

Abstract

Year:  1988        PMID： 15236090     DOI： 10.1007/s0054080020258

Source DB:  PubMed          Journal:  J Anesth        ISSN： 0913-8668            Impact factor:   2.078


× No keyword cloud information.
  38 in total

Review 1.  Extrahypothalamic thyrotropin releasing hormone (TRH) -- its distribution and its functions.

Authors:  J E Morley
Journal:  Life Sci       Date:  1979-10-29       Impact factor: 5.037

2.  Cardiovascular effects produced by injections of thyrotropin-releasing hormone in specific preoptic and hypothalamic nuclei in the rat.

Authors:  D I Diz; D M Jacobowitz
Journal:  Peptides       Date:  1984 Jul-Aug       Impact factor: 3.750

3.  Significance of acetoacetate/beta-hydroxybutyrate ratio in arterial blood as an indicator of the severity of hemorrhagic shock.

Authors:  M Yamamoto; J Tanaka; K Ozawa; T Tobe
Journal:  J Surg Res       Date:  1980-02       Impact factor: 2.192

4.  The role of plasma amino acids in hepatic encephalopathy.

Authors:  J E Fischer; J M Funovics; A Aguirre; J H James; J M Keane; R I Wesdorp; N Yoshimura; T Westman
Journal:  Surgery       Date:  1975-09       Impact factor: 3.982

5.  Cardiovascular regulation by brain acetylcholine.

Authors:  H E Brezenoff
Journal:  Fed Proc       Date:  1984-01

6.  Thyrotropin releasing hormone and naloxone attenuate the antihypertensive action of central alpha 2-adrenoceptor stimulation through different mechanisms.

Authors:  G Kunos; F Newman; C Farsang; W Ungar
Journal:  Endocrinology       Date:  1984-12       Impact factor: 4.736

7.  Identification by microinjection of TRH-sensitive sites in the cat's brain stem that mediate respiratory, temperature and other autonomic changes.

Authors:  R D Myers; G Metcalf; J C Rice
Journal:  Brain Res       Date:  1977-04-22       Impact factor: 3.252

Review 8.  Regulatory peptides as a source of new drugs--the clinical prospects for analogues of TRH which are resistant to metabolic degradation.

Authors:  G Metcalf
Journal:  Brain Res       Date:  1982-11       Impact factor: 3.252

9.  Alteration of leukotriene D4 hypotension by thyrotropin releasing hormone.

Authors:  W E Lux; G Feuerstein; A I Faden
Journal:  Nature       Date:  1983-04-28       Impact factor: 49.962

10.  Permeability of the blood-cerebrospinal fluid and blood-brain barriers to thyrotropin-releasing hormone.

Authors:  B V Zloković; M B Segal; D J Begley; H Davson; L Rakić
Journal:  Brain Res       Date:  1985-12-09       Impact factor: 3.252
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.